{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:28:27Z","timestamp":1781044107298,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijrobp.2022.06.064","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:13:04Z","timestamp":1655435584000},"page":"871-882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic Disease"],"prefix":"10.1016","volume":"114","author":[{"given":"Jonas","family":"Willmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Vlaskou Badra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Adilovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiwand","family":"Ahmadsei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mayinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tanadini-Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.06.064_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0003","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0005","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0006","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0007","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0008","doi-asserted-by":"crossref","unstructured":"Wang X-S, Bai Y-F, Verma V, et al. Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated NSCLC [e-pub ahead of print]. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djac015, accessed March 1, 2022.","DOI":"10.1093\/jnci\/djac015"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0009","first-page":"10","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial","volume":"38","author":"Ost","year":"2020","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0010","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: A single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamaoncol.2020.6146","article-title":"Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: A systematic review and meta-analysis","volume":"7","author":"Lehrer","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: A prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0013","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.radonc.2022.01.019","article-title":"Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study","volume":"168","author":"Willmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0014","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.ijrobp.2016.06.451","article-title":"Brain metastasis velocity: A novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases","volume":"96","author":"Farris","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijrobp.2018.10.036","article-title":"Validity of a recently proposed prognostic grading index, brain metastasis velocity, for patients with brain metastasis undergoing multiple radiosurgical procedures","volume":"103","author":"Yamamoto","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.radonc.2019.08.011","article-title":"Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery","volume":"142","author":"McTyre","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0017","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmpb.2019.05.023","article-title":"Evaluate cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator","volume":"177","author":"Og\u0142uszka","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0018","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1080\/03610920701215639","article-title":"A stepwise AIC method for variable selection in linear regression","volume":"36","author":"Yamashita","year":"2007","journal-title":"Communications in Statistics - Theory and Methods"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0019","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/biomet\/92.4.965","article-title":"Concordance probability and discriminatory power in proportional hazards regression","volume":"92","author":"G\u00f6nen","year":"2005","journal-title":"Biometrika"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0020","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0021","doi-asserted-by":"crossref","unstructured":"Chen H, Poon I, Atenafu EG, et al. Development of a prognostic model for overall survival in patients with extracranial oligometastatic disease treated with stereotactic body radiation therapy [e-pub ahead of print]. Int J Radiat Oncol Biol Phys.https:\/\/doi.org\/10.1016\/j.ijrobp.2021.12.001, accessed March 01, 2022.","DOI":"10.1016\/j.ijrobp.2021.12.001"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2019.01.001","article-title":"The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease","volume":"133","author":"Van den Begin","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2017.01.003","article-title":"Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease","volume":"123","author":"Tanadini-Lang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0024","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1038\/s41598-020-68160-6","article-title":"Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0025","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00551","article-title":"Repeated courses of radiosurgery for new brain metastases to defer whole brain radiotherapy: Feasibility and outcome with validation of the new prognostic metric brain metastasis velocity","volume":"8","author":"Fritz","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0027","first-page":"e1934","article-title":"Survival and failure outcomes predicted by brain metastasis volumetric kinetics in melanoma patients following upfront treatment with stereotactic radiosurgery alone","volume":"9","author":"LeCompte","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0028","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/j.ijrobp.2017.06.430","article-title":"Initial brain metastasis velocity: Does the rate at which cancers first seed the brain affect outcomes?","volume":"99","author":"Soike","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.064_bib0029","first-page":"vdaa100","article-title":"Radiomic analysis of magnetic resonance imaging predicts brain metastases velocity and clinical outcome after upfront radiosurgery","volume":"2","author":"Hsu","year":"2020","journal-title":"Neurooncol Adv"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622006095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622006095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:04:43Z","timestamp":1759745083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622006095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0360301622006095"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.064","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic Disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}